BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6342681)

  • 1. Analysis of the effects of snake venom proteinases on the activity of human plasma C1 esterase inhibitor, alpha 1-antichymotrypsin and alpha 2-antiplasmin.
    Kress LF; Catanese J; Hirayama T
    Biochim Biophys Acta; 1983 Jun; 745(2):113-20. PubMed ID: 6342681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.
    Catanese J; Kress LF
    Biochim Biophys Acta; 1984 Aug; 789(1):37-43. PubMed ID: 6432051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic inactivation of human alpha 1-antichymotrypsin by metalloproteinases in snake venoms of the family Elapidae.
    Kress LF; Hufnagel ME
    Comp Biochem Physiol B; 1984; 77(3):431-6. PubMed ID: 6425006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
    Kress LF
    J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of human plasma alpha 1-antichymotrypsin by microbial proteinases.
    Kress LF
    Acta Biochim Pol; 1983; 30(2):159-64. PubMed ID: 6346768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic digestion of human plasma inter-alpha-trypsin inhibitor by snake venom metalloproteinases.
    Catanese JJ; Kress LF
    Comp Biochem Physiol B; 1985; 80(3):507-12. PubMed ID: 2408815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens.
    Molla A; Akaike T; Maeda H
    Infect Immun; 1989 Jun; 57(6):1868-71. PubMed ID: 2656524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitors of serum proteinases].
    Jendryczko A; Drózdz M
    Wiad Lek; 1985 Dec; 38(23):1654-9. PubMed ID: 2421489
    [No Abstract]   [Full Text] [Related]  

  • 10. Complexes between serpins and inactive proteinases are not thermodynamically stable but are recognized by serpin receptors.
    Enghild JJ; Valnickova Z; Thøgersen IB; Pizzo SV
    J Biol Chem; 1994 Aug; 269(31):20159-66. PubMed ID: 7519603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for neutrophil inactivation of C1 inhibitor.
    Pemberton PA; Harrison RA; Lachmann PJ; Carrell RW
    Biochem J; 1989 Feb; 258(1):193-8. PubMed ID: 2930506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.
    Brower MS; Harpel PC
    J Biol Chem; 1982 Aug; 257(16):9849-54. PubMed ID: 6980881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional role of acute phase plasma proteinase inhibitors.
    Travis J; Shieh BH; Potempa J
    Tokai J Exp Clin Med; 1988 Dec; 13(6):313-20. PubMed ID: 3152555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor.
    Stief TW; Aab A; Heimburger N
    Thromb Res; 1988 Mar; 49(6):581-9. PubMed ID: 2455361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited proteolysis of C1-inhibitor by chymotrypsin-like proteinases.
    Schoenberger OL; Sprows JL; Schechter NM; Cooperman BS; Rubin H
    FEBS Lett; 1989 Dec; 259(1):165-7. PubMed ID: 2599103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.
    Aulak KS; Davis AE; Donaldson VH; Harrison RA
    Protein Sci; 1993 May; 2(5):727-32. PubMed ID: 8495195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of human alpha 1-antichymotrypsin with chymotrypsin.
    Laine A; Davril M; Hayem A
    Eur J Biochem; 1984 Apr; 140(1):105-11. PubMed ID: 6546719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.
    Beatty K; Bieth J; Travis J
    J Biol Chem; 1980 May; 255(9):3931-4. PubMed ID: 6989830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.